Telis Bioscience Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Telis Bioscience General Information
Description
Developer of biotechnology intended to radically accelerate drug development. The company enginers high-impact protein therapeutics building an antibody design engine to safely and effectively drug any novel target, eliminating the cycles of trial and error that slow down conventional antibody development.
Contact Information
Website
www.telisbio.comCorporate Office
- 19 Blackstone Street
- Cambridge, MA 02139
- United States
Corporate Office
- 19 Blackstone Street
- Cambridge, MA 02139
- United States
Telis Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Telis Bioscience Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Telis Bioscience FAQs
-
When was Telis Bioscience founded?
Telis Bioscience was founded in 2019.
-
Where is Telis Bioscience headquartered?
Telis Bioscience is headquartered in Cambridge, MA.
-
What industry is Telis Bioscience in?
Telis Bioscience’s primary industry is Drug Discovery.
-
Is Telis Bioscience a private or public company?
Telis Bioscience is a Private company.
-
What is Telis Bioscience’s current revenue?
The current revenue for Telis Bioscience is .
-
How much funding has Telis Bioscience raised over time?
Telis Bioscience has raised $2.15M.
-
Who are Telis Bioscience’s investors?
, , and Metaplanet Holdings have invested in Telis Bioscience.
-
Who acquired Telis Bioscience?
Telis Bioscience was acquired by Alvea.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process